Dorsey Wright & Associates’s Incyte INCY Stock Holding History

Dorsey Wright & Associates’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,735	Closed	-$1.2M	–	158
2026 Q1	$1.2M	Buy	+12,735	New	+$1.27M	0.15%	119

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dorsey Wright & Associates's INCY Position: Q2 2026 in Review

Dorsey Wright & Associates sold out of Incyte (INCY) in Q2 2026, closing a stake of 12,735 shares — an estimated $1.2M sold.

Dorsey Wright & Associates first reported a position in INCY in Q1 2026 and held it in 1 quarter. The position peaked at $1.2M in Q1 2026. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

Dorsey Wright & Associates reported no remaining Incyte position as of Q2 2026 after selling out during the quarter.
Dorsey Wright & Associates sold 12,735 Incyte shares in Q2 2026, an estimated $1.2M.
Dorsey Wright & Associates first reported a position in Incyte in Q1 2026 and held it in 1 quarter.
Dorsey Wright & Associates's Incyte position peaked at $1.2M in Q1 2026.
858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.